10739721

Source:http://linkedlifedata.com/resource/pubmed/id/10739721

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021641, umls-concept:C0027051, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0205250
pubmed:issue	9
pubmed:dateCreated	2000-6-27
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10739721-10739728
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8006263
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Insulin
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0195-668X
pubmed:author	pubmed-author:HildebrandtPP
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	700-2
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:10739721-Cost-Benefit Analysis, pubmed-meshheading:10739721-Diabetes Mellitus, Type 1, pubmed-meshheading:10739721-Diabetes Mellitus, Type 2, pubmed-meshheading:10739721-Humans, pubmed-meshheading:10739721-Insulin, pubmed-meshheading:10739721-Myocardial Infarction, pubmed-meshheading:10739721-Randomized Controlled Trials as Topic
pubmed:year	2000
pubmed:articleTitle	Intensive insulin treatment of diabetic patients with myocardial infarction is highly cost-effective.
pubmed:publicationType	Clinical Trial, Editorial, Comment